The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Director Declaration

26 Apr 2016 17:35

RNS Number : 4249W
Smith & Nephew Plc
26 April 2016
 

26 April 2016

 

Smith & Nephew plc

 

DIRECTOR DECLARATION

 

In accordance with Listing Rule 9.6.14 R the Company announces that Joseph Papa, Non-Executive Director, will be joining the Board of Valeant Pharmaceuticals International, Inc (Valeant) as its Chairman and Chief Executive in early May 2016. Valeant is listed on both the New York and Toronto Stock Exchanges. In addition, Mr Papa has resigned as Chairman and Chief Executive Officer of Perrigo Company plc with effect from 25 April 2016.

 

 

Contact:

 

Susan Swabey

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)20 7401 7646

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNPGUGWCUPQGQQ

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.